Guardant Health
GH
#2613
Rank
A$8.27 B
Marketcap
$66.94
Share price
-9.56%
Change (1 day)
97.16%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2024 (TTM): -A$0.77 Billion

According to Guardant Health 's latest financial reports the company's current earnings are A$0.69 Billion. In 2023 the company made an earning of -A$0.75 Billion, an increase over its 2022 earnings that were of -A$1.03 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.77 Billion1.66%
2023 -A$0.75 Billion-26.73%
2022 -A$1.03 Billion69.96%
2021 -A$0.61 Billion56.35%
2020 -A$0.39 Billion252.69%
2019 -A$0.11 Billion-17.22%
2018 -A$0.14 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.34 Billion-58.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.79 Billion-1.56%๐Ÿ‡บ๐Ÿ‡ธ USA